🔴 LTRN is trading 6.1% down today in a pullback from its recent oncology pipeline-driven rally

LTRN is trading at $3.69 (6.1% down) as the stock pulls back from a recent pre-market jump to $4.17.

• The recent upward momentum was driven by renewed interest in the company's oncology pipeline and significant progress on FDA trial programs.
• Positive sentiment remains supported by prior FDA IND clearance for STAR-001 and multiple orphan and fast-track designations across its clinical portfolio.